Verma S - Search Results

1

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.

Verma S, Gupta M, Holmes DT, Xu L, Teoh H, Gupta S, Yusuf S, Lonn EM. Verma S, et al. Eur Heart J. 2011 Sep;32(17):2135-42. doi: 10.1093/eurheartj/ehr066. Epub 2011 Mar 17. Eur Heart J. 2011. PMID: 21415069 Clinical Trial.

2

The T-786-->C mutation in endothelial nitric oxide synthase is associated with hypertension.

Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ. Hyndman ME, et al. Among authors: verma s. Hypertension. 2002 Apr;39(4):919-22. doi: 10.1161/01.hyp.0000013703.07316.7f. Hypertension. 2002. PMID: 11967250

3

The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study.

Anderson TJ, Roberts AC, Hildebrand K, Conradson HE, Jones C, Bridge P, Edworthy S, Lonn E, Verma S, Charbonneau F. Anderson TJ, et al. Among authors: verma s. Can J Cardiol. 2003 Jan;19(1):61-6. Can J Cardiol. 2003. PMID: 12571696

4

Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals.

Verma S, Wang CH, Lonn E, Charbonneau F, Buithieu J, Title LM, Fung M, Edworthy S, Robertson AC, Anderson TJ; FATE Investigators. Verma S, et al. Eur Heart J. 2004 Oct;25(19):1754-60. doi: 10.1016/j.ehj.2004.06.039. Eur Heart J. 2004. PMID: 15451155

5

Antiatherogenic potential of red wine: clinician update.

Szmitko PE, Verma S. Szmitko PE, et al. Among authors: verma s. Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2023-30. doi: 10.1152/ajpheart.00868.2004. Epub 2005 Jan 14. Am J Physiol Heart Circ Physiol. 2005. PMID: 15653767 Free article. Review.

6

Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.

Verma S, Leiter LA, Lonn EM, Strauss MH. Verma S, et al. Eur Heart J. 2005 Jul;26(14):1347-9. doi: 10.1093/eurheartj/ehi308. Epub 2005 May 4. Eur Heart J. 2005. PMID: 15872030 No abstract available.

7

Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men.

Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E. Yan RT, et al. Among authors: verma s. J Am Coll Cardiol. 2005 Jun 21;45(12):1980-6. doi: 10.1016/j.jacc.2004.12.079. J Am Coll Cardiol. 2005. PMID: 15963396 Free article.

8

The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers.

Verma S, Wang CH, Li SH, Lonn E, Charbonneau F, Title LM, Anderson TJ; FATE Investigators. Verma S, et al. Atherosclerosis. 2005 Oct;182(2):361-5. doi: 10.1016/j.atherosclerosis.2005.02.019. Epub 2005 Mar 23. Atherosclerosis. 2005. PMID: 16159609

9

Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' Collaboration.

Strauss MH, Lonn EM, Verma S. Strauss MH, et al. Among authors: verma s. Eur Heart J. 2005 Nov;26(22):2351-3. doi: 10.1093/eurheartj/ehi574. Epub 2005 Oct 11. Eur Heart J. 2005. PMID: 16219656 No abstract available.

10

Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?

Gupta M, Lonn EM, Verma S. Gupta M, et al. Among authors: verma s. Nat Clin Pract Cardiovasc Med. 2005 Mar;2(3):124-5. doi: 10.1038/ncpcardio0123. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16265450 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,768 results

Search Page

Filters